Publication:
Effect of Glucose-Insulin Infusion on Oxidative Stress in Patients with Dilated Cardiomyopathy

dc.authorscopusid15847931000
dc.authorscopusid23472905600
dc.authorscopusid8563748300
dc.authorscopusid57214422126
dc.authorscopusid8607023500
dc.authorscopusid24400068200
dc.authorscopusid24400068200
dc.contributor.authorDiraman, E.
dc.contributor.authorDemircan, G.
dc.contributor.authorDemircan, S.
dc.contributor.authorYazici, M.
dc.contributor.authorDurna, K.
dc.contributor.authorUral, F.
dc.contributor.authorEren, Zerrin
dc.date.accessioned2020-06-21T09:24:31Z
dc.date.available2020-06-21T09:24:31Z
dc.date.issued2008
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Diraman] Emine, Department of Biology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Demi̇Rcan] Günnur, Department of Biology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Demircan] Sabri, Department of Cardiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yazící] Mustafa, Department of Cardiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Durna] Kenan, Department of Cardiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Ural] Firat, Department of Cardiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Eren] Zafer, Department of Biology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractObjective: To investigate the effect of glucose-insulin-potassium (GIK) infusion on erythrocyte antioxidant enzyme activity levels during therapy and post-therapy in patients with dilated cardiomyopathy (DCM). Methods: Forty-one patients with DCM were enrolled in the present study. GIK solution (50 U of insulin in 500 mL of 30% glucose, plus 60 mmol/L KCl), in addition to the standard treatment, was administered by 24 h infusion in 28 patients (GIK group). In the remaining 13 patients (control group), 0.9% NaCl solution was administered. Venous blood samples from all patients were collected at baseline, during therapy (2 h, 8 h, 12 h and 24 h after baseline) and after therapy (48 h after baseline). The activity levels of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSHP) were measured. Results: In the GIK group, SOD values showed a significant increase at 24 h and 48 h compared with baseline and 2 h values (P<0.05). An increasing trend in CAT activity was observed during and after GIK infusion compared with baseline (0 h) values. However, these differences were not statistically significant (P>0.05). With regard to GSHP activity, no significant change was found in the GIK group during follow-up (P>0.05). In the control group, SOD, CAT and GSHP activity levels measured during and after therapy were found to be similar to those measured at baseline (P>0.05). Conclusion: Administration of GIK solution, in addition to standard therapy, in patients with DCM may improve the metabolic scope of the disease by reducing myocardial oxidative stress. © 2008 Pulsus Group Inc. All rights reserved.en_US
dc.identifier.endpage84en_US
dc.identifier.issn1205-6626
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-45749153789
dc.identifier.startpage79en_US
dc.identifier.volume13en_US
dc.language.isoenen_US
dc.relation.ispartofExperimental and Clinical Cardiologyen_US
dc.relation.journalExperimental and Clinical Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCardiomyopathyen_US
dc.subjectGlucoseen_US
dc.subjectInsulinen_US
dc.subjectOxidative Stressen_US
dc.subjectPotassiumen_US
dc.titleEffect of Glucose-Insulin Infusion on Oxidative Stress in Patients with Dilated Cardiomyopathyen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files